GlassScriptPhysician profile
Arun Ranganath
NPI 1720224223
$3,949.18
in general payments reported to CMS, 2019-2025
16 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $1,069 · 2021: $98.25 · 2022: $214 · 2023: $44.78 · 2024: $333 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820 · Travel and Lodging: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.40 |
| Travel and Lodging | $746.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $1,723.56 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,154.24 | 2022-2025 | |
| Grifols USA, LLC | $338.02 | 2019-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $249.94 | 2024 | |
| Glaxosmithkline, LLC. | $180.06 | 2019-2024 | Nucala |
| Mallinckrodt Enterprises LLC | $38.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.65 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $37.10 | 2021-2022 | |
| Precision Spine, INC. | $32.68 | 2019 | |
| Verona Pharma, INC. | $31.85 | 2025 | Ohtuvayre |
| Erbe USA INC | $24.28 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.84 | 2022 | |
| Genentech USA, INC. | $22.53 | 2019 | |
| Advanced Respiratory, INC | $20.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Ranganath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.